Indivior
Logotype for Indivior PLC

Indivior (INDV) investor relations material

Indivior has been acquired by Supernus Pharmaceuticals Inc

Indivior Q3 2026 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Indivior PLC
Q3 2026 earnings summary29 Oct, 2026

Executive summary

  • Q3 2026 net revenue rose 13% YoY to $356M; record SUBLOCADE revenue reached $267M, up 22% YoY.

  • GAAP operating income increased to $180M from $43M and net income to $137M from $42M; adjusted EBITDA rose 76% to $211M.

  • Action Agenda execution continued ahead of the planned November 2 merger closing with Supernus.

Financial highlights

  • 9M 2026 revenue rose 15% YoY to $1,016M; gross profit was $875M, operating income $477M and GAAP net income $348M.

  • Q3 GAAP diluted EPS was $1.12 versus $0.33; 9M GAAP diluted EPS was $2.78 versus $0.85.

  • Q3 non-GAAP net income was $161M ($1.32 diluted EPS); 9M non-GAAP net income was $427M ($3.41 diluted EPS).

  • GAAP operating expenses fell 33% YoY to $125M; non-GAAP operating expenses fell 29% to $103M.

  • 9M operating cash flow rose to $317M from $194M; cash and equivalents were $305M at September 30, while cash and investments totaled $332M.

Outlook and guidance

  • Standalone FY 2026 guidance: revenue $1,295M–$1,365M; SUBLOCADE revenue $1,010M–$1,050M; non-GAAP operating expenses $430M–$450M; adjusted EBITDA $700M–$740M.

  • Guidance assumes no material change in key exchange rates versus 2025 averages; it ceases to apply if the merger closes November 2.

  • Rest-of-World revenue is expected to decline substantially after market exits; Q4 capex is expected to be $10M, primarily for the Raleigh facility.

  • Liquidity is expected to cover anticipated cash needs for at least 12 months, conditional on sustained sales and no material change in collections and rebate-payment timing.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.
Indivior
Cover every name on your watchlist this earnings season.
Automations, AI chat, and live calls across 16,000+ companies.
Book demo

AI chat

Ask anything. Verify everything.

Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn more

Find what matters

AI across all first-party IR material. Live calls, transcripts, slides, filings.
A cited source card from Adobe's CFO alongside a list of forward-looking statements

Trust every finding

50m+ first-party documents. Every output traceable to its source.

Automations

Zero in on what matters

Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more
An automation set to trigger on the first published earnings document for GE Aerospace

Event-triggered research

Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.
An automation scheduled to run weekly on Mondays at 09:00

Scheduled research

Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.

Live audio & transcripts

Be first

Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more
A live LVMH Q2 2026 earnings call playing in Quartr

Live earnings calls

Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.
A live transcript excerpt from LVMH's Chairman and CEO Bernard Arnault

Live transcripts

Speaker-by-speaker, in real time. Searchable across every live and historical call.

Quartr MCP connects your AI environment to 17K+ public companies

Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more

Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.

Jamie Ross

Investment Manager, GAM Investments

GAM
GAM

Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.

Tom O'Hara

Investment Director

Ciena
Ciena

Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.

Gregg Lampf

VP of Investor Relations

Frequently asked questions

Indivior PLC is a pharmaceutical company focused on developing treatments for substance use disorders and mental health conditions. The company's core business revolves around the research, development, and commercialization of therapies aimed at addressing opioid dependence, alcohol use disorder, and other addiction-related conditions. Indivior also provides products in the area of behavioral health, contributing to the treatment of mental health conditions. Its portfolio includes both oral and injectable treatment options, designed to support patients in managing chronic conditions related to substance dependence. The company is headquartered in North Chesterfield, Virginia, and its shares are listed on the London Stock Exchange.